偏头痛堕胎药物对良性性性发性定位性的影响 - - 数据库分析
Audiology & neuro-otology
|May 11, 2025
概括
与没有BPPV的患者相比,患有良性偏头痛的位置性 (BPPV) 的偏头痛患者更频繁地使用静脉缩药物三药. 素基因相关 (CGRP) 抗剂可能是预防偏头痛患者BPPV的首选替代品.
科学领域:
- 神经学 神经学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 偏头痛患者对良性偏头痛定位 (BPPV) 的敏感性增加.
- 病理生理学可能涉及内耳缺血由于偏头痛相关的血管.
- 目前还没有关于在偏头痛患者中预防BPPV的指导方针.
研究的目的:
- 为了确定偏头痛患者中BPPV的患病率.
- 为了调查BPPV和流产性偏头痛药物选择之间的关联.
- 为了比较BPPV和没有BPPV的偏头痛患者使用的三和CGRP抗剂.
主要方法:
- 使用联合电子医疗记录 (2019-2024) 的基于人口的病例控制研究.
- 纳入标准:偏头痛诊断 (G43) 和前置系统疾病 (H81).
- 排除标准:头部创伤,耳部手术,维生素D缺乏. 通过奇方位分析比较平坦/CGRP抗剂的使用情况.
主要成果:
- 偏头痛的患病率在女性 (17.06%) 比男性 (7.26%) 高.
- 在BPPV患者 (30.90%) 和非BPPV患者 (25.35%) 中,三胺的使用量显著更高.
- 在非BPPV患者 (3.17%) 和BPPV患者 (2.45%) 中,CGRP抗剂的使用率更高.
结论:
- 患有BPPV的偏头痛患者暴露于三类药物更高,暴露于CGRP抗剂更低.
- 类药物可能通过血管收缩和内耳缺血增加BPPV的患病率.
- 在偏头痛患者的BPPV预防中,CGRP抗剂可能是可取的.
相关概念视频
Equilibrium and Balance
4.3K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
4.3K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
184
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
184
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
151
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
151
Pathophysiology of Vomiting
244
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
244
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
194
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
194
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
137
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
137


